Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices 12983 

2. Title of the Form/Collection: 

Application for Individual 

Manufacturing Quota for a Basic Class 

of Controlled Substance and for 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Form 189. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): None. 

Abstract: Pursuant to 21 U.S.C. 826(c) 

and 21 CFR 1303.22 and 1315.22, any 

person who is registered to manufacture 

any basic class of controlled substances 

listed in Schedule I or II, or the List I 

chemicals ephedrine, pseudoephedrine, 

or phenylpropanolamine, and who 

desires to manufacture a quantity of 

such class or such List I chemical, must 

apply on DEA Form 189 for a 

manufacturing quota for such quantity 

of such class or List I chemical. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates 33 

respondents complete 859 DEA Form 

189 applications annually, and that each 

form takes 0.5 hours to complete. 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: The DEA estimates 

this collection takes a total of 430 

annual burden hours. 

If additional information is required, 

please contact: Melody Braswell, 

Department Clearance Officer, United 

States Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: March 2, 2022. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–04786 Filed 3–7–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0008] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection; Application for 

Procurement Quota for Controlled 

Substance and for Ephedrine, 

Pseudoephedrine, and 

Phenylpropanolamine; DEA Form 250 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Department of Justice, 

Drug Enforcement Administration 

(DEA), will be submitting the following 

information collection request to the 

Office of Management and Budget for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This information collection is also 

associated with the proposed 

rulemaking ‘‘Management of Quotas for 

Controlled Substances and List I 

Chemicals,’’ published in the Federal 

Register. It is likely that the final rule 

will not be published before this 

information collection expires on June 

30, 2022. If the final rule does publish 

prior to the expiration, it will be 

published as the 30-Day Notice. 

DATES: Comments are encouraged and 

will be accepted for 60 days until May 

9, 2022. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments, especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section 

(DPW), Diversion Control Division, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 776–2265. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Application for Procurement Quota for 

Controlled Substance and for 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Form 250. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): None. 

Abstract: Pursuant to 21 U.S.C. 826 

and 21 CFR 1303.12(b) and 1315.32, any 

person who desires to use, during the 

next calendar year, any basic class of 

controlled substances listed in 

schedules I or II, or the List I chemicals 

ephedrine, pseudoephedrine, or 

phenylpropanolamine for purposes of 

manufacturing must apply on DEA 

Form 250 for a procurement quota for 

such class or List I chemical. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates 344 

respondents complete 3,066 DEA Form 

250 applications annually, and that each 

form requires 0.5 hours to complete. 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: The DEA estimates 

this collection takes a total of 1,533 

annual burden hours. 

If additional information is required, 

please contact: Melody Braswell, 

Department Clearance Officer, United 

States Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 


lotter on DSK11XQN23PROD with NOTICES1
12984 Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: March 2, 2022. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–04785 Filed 3–7–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0047] 

Agency Information Collection 

Activities; Proposed eCollection, 

eComments Requested; Extension 

Without Change of a Previously 

Approved Collection; Application for 

Import Quota for Ephedrine, 

Pseudoephedrine, and 

Phenylpropanolamine; DEA Form 488 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice, will be submitting the following 

information collection request to the 

Office of Management and Budget for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This information collection is also 

associated with the proposed 

rulemaking ‘‘Management of Quotas for 

Controlled Substances and List I 

Chemicals,’’ published in the Federal 

Register. It is likely that the final rule 

will not be published before this 

information collection expires on May 

31, 2022. If the final rule does publish 

prior to the expiration, it will be 

published as the 30-Day Notice. 

DATES: Comments are encouraged and 

will be accepted for 60 days until May 

9, 2022. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments, especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section 

(DPW), Diversion Control Division, Drug 

Enforcement Administration; Mailing 

Address: 8701 Morrissette Drive, 

Springfield, Virginia 22152; Telephone: 

(571) 776–2265. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is 

necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical 

utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information proposed to be collected 

can be enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Application for Import Quota for 

Ephedrine, Pseudoephedrine, and 

Phenylpropanolamine. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

DEA Form 488. The applicable 

component within the Department of 

Justice is the Drug Enforcement 

Administration, Diversion Control 

Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, local, and 

tribal governments. 

Abstract: Pursuant to 21 U.S.C. 952 

and 21 CFR 1315.34, any person who 

desires to import the List I chemicals 

Ephedrine, Pseudoephedrine, or 

Phenylpropanolamine during the next 

calendar year must apply on DEA Form 

488 for an import quota for each such 

List I chemical. 

5. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The DEA estimates 49 

respondents complete 126 DEA Form 

488 applications annually, and that each 

form takes 0.5 hours to complete. 

Respondents complete a separate DEA 

Form 488 for each List I chemical for 

which quota is sought. 

6. An estimate of the total public 

burden (in hours) associated with the 

proposed collection: The DEA estimates 

this collection takes a total of 63 annual 

burden hours. 

If additional information is required, 

please contact: Melody Braswell, 

Department Clearance Officer, United 

States Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE, Suite 3E.405B, 

Washington, DC 20530. 

Dated: March 2, 2022. 

Melody Braswell, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2022–04787 Filed 3–7–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging Proposed Consent 

Decree 

In accordance with Departmental 

Policy, 28 CFR 50.7, notice is hereby 

given that a proposed Consent Decree in 

United States v. Polo Development, Inc., 

et al., Civil Action No. 4:20–cv–2400– 

JRA, was lodged with the United States 

District Court for the Northern District 

of Ohio on March 1, 2022. 

This proposed Consent Decree 

concerns an amended complaint filed 

by the United States against Defendants 

Polo Development, Inc., AIM Georgia, 

LLC, Joseph Zdrilich, Donna Zdrilich, 

and Carbon Hills, LLC, pursuant to 

Section 309(b) of the Clean Water Act, 

33 U.S.C. 1319(b), to obtain injunctive 

relief from and impose civil penalties 

against the Defendants for violating 

Section 301(a) of the Clean Water Act, 

33 U.S.C. 1311(a), by discharging 

pollutants without a permit into waters 

of the United States. The proposed 

Consent Decree resolves these claims by 

requiring the Defendants to restore 

impacted areas, record a conservation 

easement, and pay a civil penalty. 

The Department of Justice will accept 

written comments relating to this 

proposed Consent Decree for thirty (30) 

days from the date of publication of this 

Notice. Please address comments to 

Patrick R. Jacobi, United States 

Department of Justice, Environment and 

Natural Resources Division, 

Environmental Defense Section, Denver 

Place Building, 999 18th Street, Suite 

370—South Terrace, Denver, CO 80202, 

pubcomment_eds.enrd@usdoj.gov, and 

refer to United States v. Polo 

Development, Inc., et al., DJ #’s 90–5–1– 

1–21099, 90–5–1–1–22034. 

Subject to public health protocols, the 

proposed Consent Decree may be 


lotter on DSK11XQN23PROD with NOTICES1